{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:07:39Z","timestamp":1784732859682,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto Valenciano de Oncolog\u00eda, Valencia, Spain","award":["Grant 2018"],"award-info":[{"award-number":["Grant 2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The clinical evolution of solitary fibrous tumors (SFTs) is often uncertain and several risk stratification systems (RSS) have been proposed. The Demicco et al. RSS is the most frequently implemented. In this study we aim to validate two alternative RSS (Sugita et al. and G-Score) using results for the Demicco RSS from a previous study of 97 SFTs. In addition, we aim to determine whether reclassified cases had any distinctive molecular features. As the Sugita et al. system substitutes mitotic count with Ki-67 index we also investigated whether Ki-67 results for tissue microarrays are comparable to those obtained using whole tissue sections. In the present study we detected that many cases classified by Demicco RSS as low-risk were reclassified as intermediate risk using the new system (G-score RSS). Kaplan-Meier survival plots for G-Score RSS showed that the low-risk and intermediate-risk SFTs had a similar evolution that contrasted with the more aggressive high-risk group. Moreover, the similar evolution in both low and intermediate-risk groups occurred despite the G-score system being stricter in classifying low-risk tumors. We observed that Sugita RSS does not provide any better risk stratification in comparison with the Demicco RSS, and testing both RSS in our series produced similar Kaplan-Meier survival data. We found some discordant results when comparing whole sections and the corresponding tissue microarrays samples, finding the hotspot areas easier to locate in whole sections. Forty-one SFTs with initial low-risk assigned by the Demicco RSS were reclassified as intermediate-risk by G-score finding both TP53 and HTER mutations in four cases, only HTER mutation in 11 cases, and only TP53 mutation in 2 cases. All six cases of SFT classified as high-risk by both the Demicco and G-score RSS suffered recurrence\/metastasis, and half showed both TP53 and HTER mutations. Five SFTs were categorized as low-risk by both Demicco and G-score, of which 4 cases revealed HTER mutation. Regarding the outcome of these 5 patients, two were lost to follow-up, and one of the remaining three patients suffered recurrence. We believe that although the presence of both TP53 and HTER mutations may confer or be related to poor evolution, the isolated presence of HTER mutation alone would not necessarily be related to poor outcome. The G-score RSS more accurately identified low-risk patients than the other two risk models evaluated in the present series. Late recurrence\/metastasis may occasionally be observed even in low-risk SFTs categorized by stricter classification systems such as the G-score RSS. These findings support the possibility that additional, as yet unknown factors may influence the clinical evolution of SFTs. In conclusion, given the possibility of late recurrence, long-term follow-up is recommended for all SFT patients, even in cases classified as low risk by the stricter G-score system. An integration of clinical, radiological, pathological, and molecular findings may improve SFT risk stratification and better predict patient outcome.<\/jats:p>","DOI":"10.3390\/ijms24010439","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T05:42:48Z","timestamp":1672206168000},"page":"439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?"],"prefix":"10.3390","volume":"24","author":[{"given":"Isidro","family":"Machado","sequence":"first","affiliation":[{"name":"Pathology Department, Instituto Valenciano de Oncolog\u00eda, 46009 Valencia, Spain"},{"name":"Patologika Laboratory, Pathology Department, Hospital Quiron-Salud, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-8247","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Bl\u00e1zquez Bujeda","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Giner","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital \u201cLa Fe\u201d, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-4691","authenticated-orcid":false,"given":"Mar\u00eda Gema","family":"Nieto Morales","sequence":"additional","affiliation":[{"name":"Zoology Department, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Cruz","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto Valenciano de Oncolog\u00eda, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Lavernia","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Valenciano de Oncolog\u00eda, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Navarro","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ferrandez","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Ruiz-Sauri","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Llombart-Bosch","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Valencia, 46009 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"key":"ref_1","first-page":"313","article-title":"Solitary fibrous tumor: An evolving and unifying entity with unsettled issues","volume":"34","author":"Huang","year":"2019","journal-title":"Histol. Histopathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13000-021-01095-2","article-title":"The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior","volume":"16","author":"Tariq","year":"2021","journal-title":"Diagn. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","article-title":"Solitary fibrous tumor: A clinicopathological study of 110 cases and proposed risk assessment model","volume":"25","author":"Demicco","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2017.54","article-title":"Risk assessment in solitary fibrous tumors: Validation and refinement of a risk stratification model","volume":"30","author":"Demicco","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/his.13940","article-title":"Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour","volume":"75","author":"Demicco","year":"2019","journal-title":"Histopathology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/annonc\/mdx250","article-title":"Prediction of local and metastatic recurrence in solitary fibrous tumor: Construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database","volume":"28","author":"Salas","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejso.2016.01.023","article-title":"Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study","volume":"42","author":"Pasquali","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/pin.12894","article-title":"Controversial issues in soft tissue solitary fibrous tumors: A pathological and molecular review","volume":"70","author":"Machado","year":"2020","journal-title":"Pathol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00428-019-02660-3","article-title":"Solitary fibrous tumor: A case series identifying pathological adverse factors-implications for risk stratification and classification","volume":"476","author":"Machado","year":"2020","journal-title":"Virchows Arch."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Machado, I., Nieto Morales, M.G., Cruz, J., Lavernia, J., Giner, F., Navarro, S., Ferrandez, A., and Llombart-Bosch, A. (2021). Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179423"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12957-022-02497-2","article-title":"Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index","volume":"20","author":"Sugita","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_12","first-page":"123","article-title":"Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour","volume":"27","author":"Georgiesh","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/modpathol.2015.70","article-title":"Solitary fibrous tumors: Loss of chimeric protein expression and genomic instability mark dedifferentiation","volume":"28","author":"Dagrada","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/cncr.32911","article-title":"Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet","volume":"126","author":"Haas","year":"2020","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/PAS.0000000000001717","article-title":"CD34-negative Solitary Fibrous Tumor: A Clinicopathologic Study of 25 Cases and Comparison With Their CD34-positive Counterparts","volume":"45","author":"Dermawan","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/PAS.0b013e318219cd0b","article-title":"Malignant fat-forming solitary fibrous tumor (so-called \u201clipomatous hemangiopericytoma\u201d): Clinicopathologic analysis of 14 cases","volume":"35","author":"Lee","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/PAS.0000000000000625","article-title":"Analysis of NAB2-STAT6 Gene Fusion in 17 Cases of Meningeal Solitary Fibrous Tumor\/Hemangiopericytoma: Review of the Literature","volume":"40","author":"Yuzawa","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/PAS.0000000000001875","article-title":"Misleading Morphologic and Phenotypic Features (Transdifferentiation) in Solitary Fibrous Tumor of the Head and Neck: Report of 3 Cases and Review of the Literature","volume":"46","author":"Michal","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/PAS.0000000000001829","article-title":"Solitary Fibrous Tumors of the Female Genital Tract: A Study of 27 Cases Emphasizing Nonvulvar Locations, Variant Histology, and Prognostic Factors","volume":"46","author":"Devins","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00000478-200107000-00008","article-title":"Solitary fibrous tumor of the oral soft tissues: A clinicopathologic and immunohistochemical study of 16 cases","volume":"25","author":"Alawi","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/PAS.0000000000000940","article-title":"Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study","volume":"41","author":"Smith","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAS.0b013e31826a92f5","article-title":"Intrapulmonary solitary fibrous tumors: Clinicopathologic and immunohistochemical study of 24 cases","volume":"37","author":"Rao","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0000000000000137","article-title":"STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors","volume":"38","author":"Yoshida","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Suster, D.I., Mackinnon, A.C., Mejbel, H.A., Gross, J.M., and Suster, S. (2022). Epithelioid and Clear Cell Solitary Fibrous Tumors: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 13 Cases. Am. J. Surg. Pathol., 18.","DOI":"10.1097\/PAS.0000000000001983"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/PAS.0b013e31817a8a89","article-title":"Pleuro-pulmonary solitary fibrous tumors: A clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha\/beta), c-met, and EGFR","volume":"32","author":"Chirosi","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/his.13703","article-title":"TERT promoter mutations in solitary fibrous tumour","volume":"73","author":"Demicco","year":"2018","journal-title":"Histopathology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00109-019-01815-8","article-title":"Molecular changes in solitary fibrous tumor progression","volume":"97","author":"Park","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bianchi, G., Lana, D., Gambarotti, M., Ferrari, C., Sbaraglia, M., Pedrini, E., Pazzaglia, L., Sangiorgi, L., Bartolotti, I., and Dei Tos, A.P. (2021). Clinical, Histological, and Molecular Features of Solitary Fibrous Tumor of Bone: A Single Institution Retrospective Review. Cancers, 13.","DOI":"10.3390\/cancers13102470"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4149\/neo_2021_210511N642","article-title":"Determination of biological behavior of solitary fibrous tumors: Correlation of expression of Ki-67, TPX2 and TERT mRNA subunit level and NAB2-STAT6 fusion compared to morphological aspects of SFTs","volume":"69","author":"Odintsov","year":"2022","journal-title":"Neoplasma"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-019-01968-3","article-title":"Prognostic significance of NAB2-STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors\/hemangiopericytomas of the CNS: Not (yet) clear","volume":"137","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Salguero-Aranda, C., Mart\u00ednez-Reguera, P., Marcilla, D., de \u00c1lava, E., and D\u00edaz-Mart\u00edn, J. (2021). Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors. Cancers, 13.","DOI":"10.3390\/cancers13205237"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.humpath.2014.11.018","article-title":"Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential","volume":"46","author":"Akaike","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jclinpath-2018-205132","article-title":"Telomerase promoter mutations and copy number alterations in solitary fibrous tumours","volume":"71","author":"Lin","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2559.2011.03997.x","article-title":"Dedifferentiated solitary fibrous tumour of the nasal cavity: The first case reported with molecular characterization of a TP53 mutation","volume":"59","author":"Subramaniam","year":"2011","journal-title":"Histopathology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00428-022-03396-3","article-title":"Clinicopathologic characterization and assessment of prognostic factors for intraabdominal solitary fibrous tumors involving the gastrointestinal tract and liver","volume":"481","author":"Liu","year":"2022","journal-title":"Virchows Arch."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00428-019-02650-5","article-title":"Histological and molecular features of solitary fibrous tumor of the extremities: Clinical correlation","volume":"476","author":"Bianchi","year":"2020","journal-title":"Virchows Arch."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Alexiev, B.A., Finkelman, B.S., Streich, L., Bautista, M.M., Pollack, S.M., Jennings, L.J., and Brat, D.J. (2021). Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis. Pathol. Res. Pract., 224.","DOI":"10.1016\/j.prp.2021.153531"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/modpathol.2016.126","article-title":"TERT promoter mutations and prognosis in solitary fibrous tumor","volume":"29","author":"Bahrami","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/PAS.0000000000001027","article-title":"Superficial Solitary Fibrous Tumor: A Series of 26 Cases","volume":"42","author":"Feasel","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.soc.2022.03.009","article-title":"Toward Better Understanding and Management of Solitary Fibrous Tumor","volume":"31","author":"Kazazian","year":"2022","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2217\/fon-2021-0030","article-title":"Solitary fibrous tumor: Molecular hallmarks and treatment for a rare sarcoma","volume":"17","author":"Smrke","year":"2021","journal-title":"Future Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1470-2045(19)30826-5","article-title":"Pazopanib for treatment of typical solitary fibrous tumours: A multicentre, single-arm, phase 2 trial","volume":"21","author":"Cruz","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:52:36Z","timestamp":1760147556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010439"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010439","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]}}}